Amphetamine-induced conditioned place preference and modeling domains of bipolar disorder

Open Neuropsychopharmacology Journal

Volumn 4, Issue 1, 2011, Pages 18-24

  Flaisher Grinberg, Shlomit ^a,b   Einat, Haim ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Affective disorders; Animal models; Mood stabilizers; Pleasure seeking

Indexed keywords

AMPHETAMINE; LITHIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REWARD;

EID: 80053527674     PISSN: None     EISSN: 18765238     Source Type: Journal    
DOI: 10.2174/1876523801104010018     Document Type: Article

References (47)

1. Sadock JB, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry. 10 ed. Philadelphia: Lippincott & Williams 2007.
2. Tecott LH, Nestler EJ. Neurobehavioral assessment in the information age. Nat Neurosci 2004; 7: 462-6.
3. Gould TD, Einat H. Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement. Neurosci Biobehav Rev 2007; 31: 825-31.
4. Gessa GL, Pani L, Serra G, Fratta W. Animal models of mania. Adv Biochem Psychopharmacol 1995; 49: 43-66.
5. Malatynska E, Knapp RJ. Dominant-submissive behavior as models of mania and depression. Neurosci Biobehav Rev 2005; 29: 715-37.
6. Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behav Genet 2007; 37: 244-55.
7. Einat H. Modelling facets of mania-new directions related to the notion of endophenotypes. J Psychopharmacol 2006; 20: 714-22.
8. Einat H. Different behaviors and different strains: potential new ways to model bipolar disorder. Neurosci Biobehav Rev 2007; 31: 850-7.
9. Einat H, Shaldubina A, Bersudskey Y, Belmaker RH. In: Soares JC, Young A, Eds. Bipolar disorders: basic mechanisms and therapeutic implications. 2nd ed. New York: Taylor & Francis 2007.
10. Hiscock KM, Linde JA, Einat H. Black Swiss mice as a new animal model for mania: a preliminary study. J Med Biol Sci 2007; 1: 1-7.
11. Flaisher-Grinberg S, Einat H. Strain Specific battery of tests for separate behavioral domains of mania. Front Psychiatry 2010; 1: 1-10.
12. Flaisher-Grinberg S, Overgaard S, Einat H. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania. J Neurosci Methods 2009; 177: 44-50.
13. Flaisher-Grinberg S, Einat H. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior. J Pharmacol Toxicol Methods 2009; 59: 141-5.
14. Malkesman O, Scattoni ML, Paredes D, et al. The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry 2009; 67: 864-71.
15. Johnson SL. Mania and dysregulation in goal pursuit: a review. Clin Psychol Rev 2005; 25: 241-62.
16. Abler B, Greenhouse I, Ongur D, Walter H, Heckers S. Abnormal reward system activation in mania. Neuropsychopharmacology 2007; 7: 7.
17. Abler B, Erk S, Walter H. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. Psychopharmacology (Berl) 2007; 191: 823-33.
18. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006; 60: 93-105.
19. Schechter MD, Calcagnetti DJ. Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci Biobehav Rev 1993; 17: 21-41.
20. Bardo MT, Bevins RA. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 2000; 153: 31-43.
21. Spyraki C, Fibiger HC, Phillips AG. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res 1982; 253: 185-93.
22. Adriani W, Laviola G. Spontaneous novelty seeking and amphetamine-induced conditioning and sensitization in adult mice: evidence of dissociation as a function of age at weaning. Neuropsychopharmacology 2002; 27: 225-36.
23. Bowling SL, Bardo MT. Locomotor and rewarding effects of amphetamine in enriched, social, and isolate reared rats. Pharmacol Biochem Behav 1994; 48: 459-64.
24. Anand A, Verhoeff P, Seneca N, et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 2000; 157: 1108-14.
25. Huey LY, Janowsky DS, Judd LL, Abrams A, Parker D, Clopton P. Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes. Psychopharmacology (Berl) 1981; 73: 161-4.
26. Van Kammen DP, Murphy DL. Attenuation of the euphoriant and activating effects of d-and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 1975; 44: 215-24.
27. You ZD, Li JH, Song CY, Lu CL, He C. Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats. Neurosci Res 2001; 41: 143-50.
28. Mu P, Yu LC. Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. Neurosci Lett 2007; 426: 135-8.
29. Spyraki C, Kazandjian A, Varonos D. Diazepam-induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacology (Berl) 1985; 87: 225-32.
30. Shippenberg TS, Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur J Pharmacol 1995; 280: 55-61.
31. Gould TD, O'Donnell KC, Picchini AM, Manji HK. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 2007; 32: 1321-33.
32. Wang J, Flaisher-Grinberg S, Li S, et al. Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice. J Ethnopharmacol 2010; 132: 65-9.
33. Kalinichev M, Dawson LA. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK-3) inhibitors in a strain specific model of acute mania. Int J Neuropsychopharmacol 2011; 6: 1-17.
34. Papp M, Gruca P, Willner P. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMAreceptor antagonist. Neuropsychopharmacology 2002; 27(5): 727-43.
35. Einat H, Szechtman H. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Behav Brain Res 1993; 54: 35-41.
36. Cryan JF, Slattery DA. Animal models of mood disorders: Recent developments. Curr Opin Psychiatry 2007; 20: 1-7.
37. Machado-Vieira R, Kapczinski F, Soares JC. Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 209-24.
38. Krivisky K, Ashkenazy T, Kronfeld-Schor N, Einat H. Antidepressants reverse short-photoperiod-induced, forced swim test depression-like behavior in the diurnal fat sand rat: further support for the utilization of diurnal rodents for modeling affective disorders. Neuropsychobiology 2011; 63: 191-6.
39. Shafrir E, Gutman A. Psammomys obesus of the Jerusalem colony: a model for nutritionally induced, non-insulin-dependent diabetes. J Basic Clin Physiol Pharmacol 1993; 4: 83-99.
40. Benjamin J, Ebstein RP, Lesch KP. Genes for personality traits: implications for psychopathology. Int J Neuropsychopharmacol 1998; 1: 153-168.
41. Willner P. In: Willner P, Ed. Behavioral models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge, Cambridge University Press 1991. pp. 3-19.
42. Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 1984; 83: 1-16.
43. Parmentier-Batteur S, Obrien JA, Doran S, et al. Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration. Neuropharmacology 2010; 2010: 26.
44. Bast T, Pezze MA, Feldon J. Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamineinduced activity and does not affect prepulse inhibition. Behav Pharmacol 2002; 13: 669-73.
45. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 2007; 56: 27-78.
46. Valvassori SS, Rezin GT, Ferreira CL, et al. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res 2010; 44: 903-9.
47. Hannah-Poquette C, Anderson GW, Flaisher-Grinberg S, Wang J, Meinerding TM, Einat H. Modeling mania: further validation for Black Swiss as model animals. Behav Brain Res 2011: 223: 222-6.